Free Trial
OTCMKTS:LTUS

Lotus Pharmaceuticals (LTUS) Stock Price, News & Analysis

Lotus Pharmaceuticals logo
$0.0085 +0.00 (+39.34%)
As of 01:06 PM Eastern

About Lotus Pharmaceuticals Stock (OTCMKTS:LTUS)

Key Stats

Today's Range
$0.0085
$0.0098
50-Day Range
$0.0044
$0.0111
52-Week Range
$0.0006
$0.0111
Volume
21,895 shs
Average Volume
47,346 shs
Market Capitalization
$22.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive LTUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lotus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

LTUS Stock News Headlines

PTT to sell stake in Taiwan pharmaceuticals firm
Critical AI announcement set to ignite AI 2.0
I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.
Lotus Pharmaceutical Co Ltd (1795) - Investing.com UK
Lotus Pharmaceuticals Inc Price / Book
See More Headlines

LTUS Stock Analysis - Frequently Asked Questions

Lotus Pharmaceuticals' stock was trading at $0.0060 at the beginning of 2025. Since then, LTUS stock has increased by 41.7% and is now trading at $0.0085.

Shares of LTUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Lotus Pharmaceuticals investors own include Vodafone Group (VOD), TILT (TLLTF), SolarWinds (SWI), Spectra Energy Partners (SEP), NextEra Energy (NEE), Energy Transfer (ET) and Ameriwest Lithium (AWLID).

Company Calendar

Today
7/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:LTUS
CIK
N/A
Employees
230
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
2,644,520,000
Free Float
N/A
Market Cap
$22.48 million
Optionable
Not Optionable
Beta
-2.48

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:LTUS) was last updated on 7/28/2025 by MarketBeat.com Staff
From Our Partners